Production (Stage)
Generation Bio Co.
GBIO
$0.3691
-$0.0139-3.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.93M | -131.67M | -145.47M | -158.43M | -169.06M |
| Total Depreciation and Amortization | 4.76M | 4.93M | 5.08M | 5.19M | 5.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.17M | 69.60M | 67.76M | 68.76M | 69.47M |
| Change in Net Operating Assets | -31.22M | -31.43M | -25.12M | -18.63M | 37.58M |
| Cash from Operations | -85.23M | -88.56M | -97.76M | -103.11M | -56.77M |
| Capital Expenditure | -729.00K | -2.40M | -6.60M | -7.12M | -8.56M |
| Sale of Property, Plant, and Equipment | 226.00K | 196.00K | 149.00K | 104.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.54M | 96.73M | 28.79M | -9.94M | 3.93M |
| Cash from Investing | 98.04M | 94.53M | 22.33M | -16.96M | -4.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 436.00K | 436.00K | 457.00K | 444.00K | 546.00K |
| Repurchase of Common Stock | -68.00K | -186.00K | -289.00K | -404.00K | -491.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 15.00K | 15.00K | -135.00K |
| Cash from Financing | 368.00K | 250.00K | 183.00K | 55.00K | -80.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.18M | 6.22M | -75.24M | -120.01M | -61.48M |